NCT06256055 2024-07-24
Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors
UTC Therapeutics Inc.
Phase 1 Unknown
Clinical Trials
40 trialsNCT06281860 2024-02-28
PITHAC
Centre Hospitalier Universitaire Vaudois
Phase 1 Unknown
NCT04823741 2024-02-01
SCITH-MESO
Hospices Civils de Lyon
Unknown
NCT05278975 2024-01-26
Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma
RS Oncology LLC
Phase 1/2 Unknown
NCT05498597 2023-10-19
AMT-151 in Patients With Selected Advanced Solid Tumours
Multitude Therapeutics Inc.
Phase 1 Unknown
NCT05910112 2023-06-18
PROSPECT
University of Oxford
Unknown
NCT03654833 2023-03-14
MiST
University of Leicester
Phase 2 Unknown
NCT05429866 2023-03-08
Immunological Variables Associated to ICI Toxicity in Cancer Patients
Jules Bordet Institute
Phase 2 Unknown
NCT03475953 2023-03-03
REGOMUNE
Institut Bergonié
Phase 1/2 Unknown
NCT02436733 2022-11-07
Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM
European Organisation for Research and Treatment of Cancer - EORTC
Phase 2 Unknown
NCT05598268 2022-10-28
A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.
ImmVira Pharma Co. Ltd
Phase 1/2 Unknown
NCT05508555 2022-08-22
Effect of HITHOC After Pleurectomy Decortication for Treatment of Malignant Pleural Mesothelioma
Ain Shams University
Phase NA Unknown
NCT04013334 2022-06-16
MTG201 Plus Nivolumab in Patients With Relapsed Pleural Mesothelioma
Momotaro-Gene Inc.
Phase 2 Unknown
NCT05077111 2021-10-14
VATS
Ain Shams University
Phase 4 Unknown
NCT05042557 2021-09-13
Real World Study of MPM in China
ChineseAMS
Unknown
NCT03852823 2021-04-30
Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Phase 1 Unknown
NCT04713761 2021-01-26
Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2 Unknown
NCT04462809 2020-07-09
TALAMESO
Hospices Civils de Lyon
Phase 2 Unknown
NCT03210298 2019-10-08
PIPACRegis
University of Magdeburg
Unknown
NCT03558932 2018-06-15
IP3R Modulation by Cancer Genes in Mesothelioma
KU Leuven
Unknown
NCT02761863 2018-02-23
Effect of Expression of CD74 and VEGF on Outcome of Treatment in Patients With Malignant Pleural Mesothelioma
Ain Shams University
Unknown
NCT03290183 2017-09-21
Confocal Laser Endomicroscopy in Pleural Malignancies
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Unknown
NCT02755675 2016-11-21
uPAR-PET for Prognostication in Patients With Non-small Cell Lung Cancer, Malignant Pleural Mesothelioma and Large Cell Neuroendocrine Carcinoma of the Lung
Rigshospitalet, Denmark
Phase 2 Unknown
NCT02588131 2015-10-27
A Study of Tremelimumab Combined With the Anti-PD-L1 MEDI4736 Antibody in Malignant Mesothelioma (NIBIT-MESO-1)
Italian Network for Tumor Biotherapy Foundation
Phase 2 Unknown
NCT02580747 2015-10-20
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso
Chinese PLA General Hospital
Phase 1 Unknown
NCT00969098 2015-08-06
Response Evaluation in Malignant Pleural Mesothelioma
Istituto Clinico Humanitas
Unknown
NCT02497053 2015-07-14
Four Versus Six Cycles of Pemetrexed/Platinum for MPM
Ain Shams University
Phase 2 Unknown
NCT01279967 2014-11-20
ADAM
Barts & The London NHS Trust
Phase 2 Unknown
NCT00024271 2014-01-06
Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00002465 2013-11-06
High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma
National Cancer Institute (NCI)
Phase 1/2 Unknown
NCT00003034 2013-11-06
ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00006216 2013-09-20
Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00030459 2013-08-07
Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01655888 2012-08-02
The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma
Azienda Ospedaliera Universitaria Senese
Phase 2 Unknown
NCT01649024 2012-07-25
A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma
Azienda Ospedaliera Universitaria Senese
Phase 2 Unknown
NCT00996385 2011-10-31
Velcade and Eloxatin for Patients With Malignant Pleural or Peritoneal Mesothelioma
Columbia University
Phase 2 Unknown
NCT01343264 2011-04-28
Trimodality Therapy for Malignant Pleural Mesothelioma
HSK Wiesbaden
Unknown
NCT00899613 2009-12-15
Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperplasia
National Cancer Institute (NCI)
Unknown
NCT00253409 2009-07-14
Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma That Can Be Removed By Surgery
National Cancer Institute (NCI)
Phase NA Unknown
NCT00886028 2009-04-22
Palliative Treatment With Liposomal Doxorubicin Plus Cisplatin for Patients With Malignant Pleural Mesothelioma
National Institute of Cancerología
Phase 2 Unknown